263 related articles for article (PubMed ID: 29517104)
1. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
Wu S; Ai N; Liu Q; Zhang J
Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF‑mediated PI3K/AKT signalling pathway.
Song D; Diao J; Yang Y; Chen Y
Mol Med Rep; 2017 Nov; 16(5):6428-6436. PubMed ID: 28901408
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑330 is downregulated in retinoblastoma and suppresses cell viability and invasion by directly targeting ROCK1.
Wang L; Wang L; Li L; Zhang H; Lyu X
Mol Med Rep; 2019 Oct; 20(4):3440-3447. PubMed ID: 31432120
[TBL] [Abstract][Full Text] [Related]
5. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression.
Huang Y; Xue B; Pan J; Shen N
Exp Mol Pathol; 2021 Jun; 120():104637. PubMed ID: 33844975
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.
Guo L; Bai Y; Ni T; Li Y; Cao R; Ji S; Li S
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34036380
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway.
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
[TBL] [Abstract][Full Text] [Related]
8. microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a.
Lyu X; Wang L; Lu J; Zhang H; Wang L
Oncol Rep; 2019 May; 41(5):3137-3147. PubMed ID: 30896857
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway.
Cao Y; Xia F; Wang P; Gao M
Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation.
Huang YX; Nie XG; Li GD; Fan DS; Song LL; Zhang XL
Int J Oncol; 2018 Dec; 53(6):2615-2626. PubMed ID: 30320366
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis.
Fu K; Zhang K; Zhang X
Orphanet J Rare Dis; 2022 Mar; 17(1):119. PubMed ID: 35248107
[TBL] [Abstract][Full Text] [Related]
12. miR-29a inhibits human retinoblastoma progression by targeting STAT3.
Liu S; Zhang X; Hu C; Wang Y; Xu C
Oncol Rep; 2018 Feb; 39(2):739-746. PubMed ID: 29251322
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN.
Wei D; Miao Y; Yu L; Wang D; Wang Y
Mol Med Rep; 2018 Jul; 18(1):595-602. PubMed ID: 29749457
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin.
Zhang Y; Wang X; Zhao Y
Mol Med Rep; 2018 Sep; 18(3):3099-3105. PubMed ID: 30015932
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway.
Liu F; Zhang Q; Liang Y
J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056
[TBL] [Abstract][Full Text] [Related]
16. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.
Wang J; Wang S; Chen L; Tan J
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495818
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MEG3 attenuates the malignancy of retinoblastoma cells through inactivating PI3K /Akt/mTOR signaling pathway.
Yan X; Jia H; Zhao J
Exp Eye Res; 2023 Jan; 226():109340. PubMed ID: 36476400
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways.
Zhang M; Li Q; Pan Y; Wang H; Liu G; Yin H
Oncol Rep; 2018 Apr; 39(4):2040-2050. PubMed ID: 29436689
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑758 inhibits malignant progression of retinoblastoma by directly targeting PAX6.
Li J; You X
Oncol Rep; 2018 Sep; 40(3):1777-1786. PubMed ID: 30015924
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
